Retatrutide and Semaglutide Interaction

Avoid
Researched 95% confidence

Retatrutide and Semaglutide have a potentially harmful interaction with 95% confidence. Do not combine—overlapping GLP-1 agonist mechanisms increase severe hypoglycemia risk. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

Retatrutide

Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes

Activates GLP-1 for appetite suppression, GIP for insulin sensitivity, and glucagon for increased energy expenditure and hepatic fat oxidation..

Half-life: ~6 days Typical dose: 0.5mg starting, titrate up to 8-12mg weekly weight loss, metabolic
insulin disrupting
View full profile

Semaglutide

GLP-1 Receptor Agonist | Weight Loss & Diabetes

Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways..

Half-life: ~7 days (168 hours) Typical dose: 0.25mg starting, titrate to 1-2.4mg weekly weight loss, metabolic
glp1 receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (Retatrutide, Semaglutide). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take Retatrutide with Semaglutide?

Combining Retatrutide with Semaglutide is not recommended. Do not combine—overlapping GLP-1 agonist mechanisms increase severe hypoglycemia risk.

Is Retatrutide and Semaglutide safe together?

This combination carries significant risk. Do not combine—overlapping GLP-1 agonist mechanisms increase severe hypoglycemia risk. Consult a healthcare professional before combining.

What are the interactions between Retatrutide and Semaglutide?

Do not combine—overlapping GLP-1 agonist mechanisms increase severe hypoglycemia risk. This assessment has 95% confidence and is based on documented research data.

How should I time Retatrutide and Semaglutide?

Retatrutide has a half-life of ~6 days and Semaglutide has a half-life of ~7 days (168 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Retatrutide vs Semaglutide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.